Allen Lutz
Stock Analyst at Bank of America Securities
(4.82)
# 463
Out of 5,108 analysts
648
Total ratings
66.1%
Success rate
12.5%
Average return
Main Sectors:
Stocks Rated by Allen Lutz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Maintained: Hold | $32 | $24.06 | +33.00% | 81 | Nov 6, 2026 | |
| COR Cencora | Reiterated: Hold | $345 → $360 | $339.68 | +5.98% | 28 | Nov 5, 2026 | |
| CVS CVS Health | Reiterated: Buy | $110 → $100 | $81.33 | +22.96% | 38 | Nov 5, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,050 → $1,250 | $1,072.00 | +16.60% | 43 | Nov 5, 2026 | |
| PGNY Progyny | Reiterated: Buy | $31 → $36 | $34.37 | +4.74% | 24 | Nov 5, 2026 | |
| HSIC Henry Schein | Reiterated: Buy | $110 | $85.31 | +28.94% | 26 | Nov 4, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $38 | $28.88 | +31.58% | 27 | Nov 3, 2026 | |
| TDOC Teladoc Health | Reiterated: Buy | $11 | $9.41 | +11.58% | 83 | Oct 28, 2026 | |
| DOCS Doximity | Reiterated: Sell | $20 → $23 | $33.18 | -30.68% | 47 | Oct 20, 2026 | |
| HQY HealthEquity | Reiterated: Buy | $125 | $103.46 | +20.82% | 59 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $38.03 | - | 34 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $10.09 | +68.48% | 25 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $24.96 | +36.22% | 26 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.65 | $3.49 | -24.07% | 32 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $39.87 | +17.88% | 7 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.25 → $1.3 | $0.2981 | +336.10% | 17 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.7 | $1.13 | -38.05% | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 | $267.82 | -2.92% | 21 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $12.11 | n/a | 11 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $4.24 | n/a | 3 | Jun 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $41 | $0.0001 | n/a | 2 | Aug 10, 2022 |
Hims & Hers Health
Nov 6, 2026
Maintained: Hold
Price Target: $32
Current: $24.06
Upside: +33.00%
Cencora
Nov 5, 2026
Reiterated: Hold
Price Target: $345 → $360
Current: $339.68
Upside: +5.98%
CVS Health
Nov 5, 2026
Reiterated: Buy
Price Target: $110 → $100
Current: $81.33
Upside: +22.96%
McKesson
Nov 5, 2026
Reiterated: Buy
Price Target: $1,050 → $1,250
Current: $1,072.00
Upside: +16.60%
Progyny
Nov 5, 2026
Reiterated: Buy
Price Target: $31 → $36
Current: $34.37
Upside: +4.74%
Henry Schein
Nov 4, 2026
Reiterated: Buy
Price Target: $110
Current: $85.31
Upside: +28.94%
Waystar Holding
Nov 3, 2026
Reiterated: Buy
Price Target: $38
Current: $28.88
Upside: +31.58%
Teladoc Health
Oct 28, 2026
Reiterated: Buy
Price Target: $11
Current: $9.41
Upside: +11.58%
Doximity
Oct 20, 2026
Reiterated: Sell
Price Target: $20 → $23
Current: $33.18
Upside: -30.68%
HealthEquity
Oct 16, 2026
Reiterated: Buy
Price Target: $125
Current: $103.46
Upside: +20.82%
Oct 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $38.03
Upside: -
Oct 12, 2026
Reiterated: Buy
Price Target: $17
Current: $10.09
Upside: +68.48%
Oct 7, 2026
Reiterated: Buy
Price Target: $34
Current: $24.96
Upside: +36.22%
Sep 15, 2026
Reiterated: Sell
Price Target: $2.65
Current: $3.49
Upside: -24.07%
Sep 1, 2026
Reiterated: Buy
Price Target: $47
Current: $39.87
Upside: +17.88%
Aug 11, 2026
Reiterated: Sell
Price Target: $2.25 → $1.3
Current: $0.2981
Upside: +336.10%
Aug 11, 2026
Reiterated: Sell
Price Target: $0.7
Current: $1.13
Upside: -38.05%
Jul 20, 2026
Reiterated: Buy
Price Target: $260
Current: $267.82
Upside: -2.92%
Aug 5, 2024
Rated: Hold
Price Target: n/a
Current: $12.11
Upside: n/a
Jun 20, 2023
Reiterated: Hold
Price Target: $12
Current: $4.24
Upside: n/a
Aug 10, 2022
Reiterated: Hold
Price Target: $50 → $41
Current: $0.0001
Upside: n/a